BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawabata A, Matsunami M, Tsutsumi M, Ishiki T, Fukushima O, Sekiguchi F, Kawao N, Minami T, Kanke T, Saito N. Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice. Br J Pharmacol. 2006;148:54-60. [PMID: 16520745 DOI: 10.1038/sj.bjp.0706708] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Sekiguchi F, Koike N, Shimada Y, Sugimoto K, Masuda H, Nakamura T, Yamaguchi H, Tanabe G, Marumoto S, Kasanami Y, Tsubota M, Ohkubo T, Yoshida S, Kawabata A. A hydrolysate of poly-trans-[(2-carboxyethyl)germasesquioxane] (Ge-132) suppresses Ca(v)3.2-dependent pain by sequestering exogenous and endogenous sulfide. Redox Biol 2023;59:102579. [PMID: 36563535 DOI: 10.1016/j.redox.2022.102579] [Reference Citation Analysis]
2 Choi NR, Kim JN, Kim BJ. Trypsin Depolarizes Pacemaker Potentials in Murine Small Intestinal Interstitial Cells of Cajal. Applied Sciences 2022;12:4755. [DOI: 10.3390/app12094755] [Reference Citation Analysis]
3 Oliveira KA, Torquato RJS, Lustosa DCGG, Ribeiro T, Nascimento BWL, de Oliveira LCG, Juliano MA, Paschoalin T, Lemos VS, Araujo RN, Pereira MH, Tanaka AS. Proteolytic activity of Triatoma infestans saliva associated with PAR-2 activation and vasodilation. J Venom Anim Toxins Incl Trop Dis 2021;27:e20200098. [PMID: 33747067 DOI: 10.1590/1678-9199-JVATITD-2020-0098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Hassler SN, Kume M, Mwirigi JM, Ahmad A, Shiers S, Wangzhou A, Ray PR, Belugin SN, Naik DK, Burton MD, Vagner J, Boitano S, Akopian AN, Dussor G, Price TJ. The cellular basis of protease-activated receptor 2-evoked mechanical and affective pain. JCI Insight 2020;5:137393. [PMID: 32352932 DOI: 10.1172/jci.insight.137393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
5 Xue M, Han L, Qian W, Li J, Qin T, Xiao Y, Ma Q, Ma J, Shen X. Nitric Oxide Stimulates Acute Pancreatitis Pain via Activating the NF-κB Signaling Pathway and Inhibiting the Kappa Opioid Receptor. Oxid Med Cell Longev 2020;2020:9230958. [PMID: 32454946 DOI: 10.1155/2020/9230958] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Hassler SN, Kume M, Mwirigi JM, Ahmad A, Shiers S, Wangzhou A, Ray PR, Belugin SN, Naik DK, Burton MD, Vagner J, Boitano S, Akopian AN, Dussor G, Price TJ. The cellular basis of protease activated receptor type 2 (PAR2) evoked mechanical and affective pain.. [DOI: 10.1101/2020.01.31.928663] [Reference Citation Analysis]
7 Saloman JL, Albers KM, Cruz-Monserrate Z, Davis BM, Edderkaoui M, Eibl G, Epouhe AY, Gedeon JY, Gorelick FS, Grippo PJ, Groblewski GE, Husain SZ, Lai KKY, Pandol SJ, Uc A, Wen L, Whitcomb DC. Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer. Pancreas 2019;48:759-79. [PMID: 31206467 DOI: 10.1097/MPA.0000000000001335] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
8 Irie Y, Tsubota M, Ishikura H, Sekiguchi F, Terada Y, Tsujiuchi T, Liu K, Nishibori M, Kawabata A. Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis. J Neuroimmune Pharmacol 2017;12:693-707. [DOI: 10.1007/s11481-017-9757-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
9 Abreu FF, Souza ACA, Teixeira SA, Soares AG, Teixeira DF, Soares RC, Santana MT, Lauton Santos S, Costa SKP, Muscará MN, Camargo EA. Elucidating the role of oxidative stress in the therapeutic effect of rutin on experimental acute pancreatitis. Free Radical Research 2016;50:1350-60. [DOI: 10.1080/10715762.2016.1247494] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
10 Yau MK, Lim J, Liu L, Fairlie DP. Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015). Expert Opin Ther Pat 2016;26:471-83. [PMID: 26936077 DOI: 10.1517/13543776.2016.1154540] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
11 Tillu DV, Hassler SN, Burgos-Vega CC, Quinn TL, Sorge RE, Dussor G, Boitano S, Vagner J, Price TJ. Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state. Pain 2015;156:859-67. [PMID: 25734998 DOI: 10.1097/j.pain.0000000000000125] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
12 Anderson MA, Akshintala V, Albers KM, Amann ST, Belfer I, Brand R, Chari S, Cote G, Davis BM, Frulloni L, Gelrud A, Guda N, Humar A, Liddle RA, Slivka A, Gupta RS, Szigethy E, Talluri J, Wassef W, Wilcox CM, Windsor J, Yadav D, Whitcomb DC. Mechanism, assessment and management of pain in chronic pancreatitis: Recommendations of a multidisciplinary study group. Pancreatology 2016;16:83-94. [PMID: 26620965 DOI: 10.1016/j.pan.2015.10.015] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 8.4] [Reference Citation Analysis]
13 Atsawarungruangkit A, Pongprasobchai S. Current understanding of the neuropathophysiology of pain in chronic pancreatitis. World J Gastrointest Pathophysiol 2015; 6(4): 193-202 [PMID: 26600977 DOI: 10.4291/wjgp.v6.i4.193] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
14 Pallagi P, Hegyi P, Rakonczay Z Jr. The Physiology and Pathophysiology of Pancreatic Ductal Secretion: The Background for Clinicians. Pancreas 2015;44:1211-33. [PMID: 26465950 DOI: 10.1097/MPA.0000000000000421] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
15 Moran RA, James T, Pasricha PJ. Pancreatic pain. Curr Opin Gastroenterol 2015;31:407-15. [PMID: 26154428 DOI: 10.1097/MOG.0000000000000204] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
16 McDougall JJ, Muley MM. The role of proteases in pain. Handb Exp Pharmacol 2015;227:239-60. [PMID: 25846622 DOI: 10.1007/978-3-662-46450-2_12] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
17 Veldhuis NA, Poole DP, Grace M, Mcintyre P, Bunnett NW, Christopoulos A. The G Protein–Coupled Receptor–Transient Receptor Potential Channel Axis: Molecular Insights for Targeting Disorders of Sensation and Inflammation. Pharmacol Rev 2014;67:36-73. [DOI: 10.1124/pr.114.009555] [Cited by in Crossref: 106] [Cited by in F6Publishing: 114] [Article Influence: 11.8] [Reference Citation Analysis]
18 Suen JY, Cotterell A, Lohman RJ, Lim J, Han A, Yau MK, Liu L, Cooper MA, Vesey DA, Fairlie DP. Pathway-selective antagonism of proteinase activated receptor 2. Br J Pharmacol 2014;171:4112-24. [PMID: 24821440 DOI: 10.1111/bph.12757] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
19 Boitano S, Hoffman J, Tillu DV, Asiedu MN, Zhang Z, Sherwood CL, Wang Y, Dong X, Price TJ, Vagner J. Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tethering. PLoS One 2014;9:e99140. [PMID: 24927179 DOI: 10.1371/journal.pone.0099140] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
20 Farrell KE, Keely S, Graham BA, Callister R, Callister RJ. A systematic review of the evidence for central nervous system plasticity in animal models of inflammatory-mediated gastrointestinal pain. Inflamm Bowel Dis 2014;20:176-95. [PMID: 24284415 DOI: 10.1097/01.MIB.0000437499.52922.b1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
21 Yau MK, Liu L, Fairlie DP. Toward drugs for protease-activated receptor 2 (PAR2). J Med Chem 2013;56:7477-97. [PMID: 23895492 DOI: 10.1021/jm400638v] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
22 Flynn AN, Hoffman J, Tillu DV, Sherwood CL, Zhang Z, Patek R, Asiedu MN, Vagner J, Price TJ, Boitano S. Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering. FASEB J 2013;27:1498-510. [PMID: 23292071 DOI: 10.1096/fj.12-217323] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
23 Lee YT, Wei J, Chuang YC, Chang CY, Chen IC, Weng CF, Schmid-Schönbein GW. Successful treatment with continuous enteral protease inhibitor in a patient with severe septic shock. Transplant Proc. 2012;44:817-819. [PMID: 22483504 DOI: 10.1016/j.transproceed.2012.03.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
24 Camargol EA, Zanonil CI, Toyamal MH, Muscaral MN, Dochertyl RJ, Costal SK. Abdominal hyperalgesia in secretory phospholipase A 2 -induced rat pancreatitis: Distinct roles of NK 1 receptors. European Journal of Pain 2011;15:900-6. [DOI: 10.1016/j.ejpain.2011.04.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
25 Pallagi P, Venglovecz V, Rakonczay Z Jr, Borka K, Korompay A, Ozsvári B, Judák L, Sahin-Tóth M, Geisz A, Schnúr A, Maléth J, Takács T, Gray MA, Argent BE, Mayerle J, Lerch MM, Wittmann T, Hegyi P. Trypsin reduces pancreatic ductal bicarbonate secretion by inhibiting CFTR Cl⁻ channels and luminal anion exchangers. Gastroenterology 2011;141:2228-2239.e6. [PMID: 21893120 DOI: 10.1053/j.gastro.2011.08.039] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
26 Ceppa EP, Lyo V, Grady EF, Knecht W, Grahn S, Peterson A, Bunnett NW, Kirkwood KS, Cattaruzza F. Serine proteases mediate inflammatory pain in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2011;300:G1033-42. [PMID: 21436316 DOI: 10.1152/ajpgi.00305.2010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
27 Zhang W, Gao J, Zhao T, Wei L, Wu W, Bai Y, Zou D, Li Z. Proteinase-activated receptor 2 mediates thermal hyperalgesia and is upregulated in a rat model of chronic pancreatitis. Pancreas 2011;40:300-7. [PMID: 21311307 DOI: 10.1097/MPA.0b013e318201cbc1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
28 Takemura Y, Furuta S, Hirayama S, Miyashita K, Imai S, Narita M, Kuzumaki N, Tsukiyama Y, Yamazaki M, Suzuki T, Narita M. Upregulation of bradykinin receptors is implicated in the pain associated with caerulein-induced acute pancreatitis. Synapse 2011;65:608-16. [DOI: 10.1002/syn.20880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
29 Nishimura S, Ishikura H, Matsunami M, Shinozaki Y, Sekiguchi F, Naruse M, Kitamura T, Akashi R, Matsumura K, Kawabata A. The proteinase/proteinase-activated receptor-2/transient receptor potential vanilloid-1 cascade impacts pancreatic pain in mice. Life Sci. 2010;87:643-650. [PMID: 20932849 DOI: 10.1016/j.lfs.2010.09.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
30 Barry GD, Suen JY, Le GT, Cotterell A, Reid RC, Fairlie DP. Novel Agonists and Antagonists for Human Protease Activated Receptor 2. J Med Chem 2010;53:7428-40. [DOI: 10.1021/jm100984y] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 6.5] [Reference Citation Analysis]
31 Fukushima O, Nishimura S, Matsunami M, Aoki Y, Nishikawa H, Ishikura H, Kawabata A. Phosphorylation of ERK in the spinal dorsal horn following pancreatic pronociceptive stimuli with proteinase-activated receptor-2 agonists and hydrogen sulfide in rats: Evidence for involvement of distinct mechanisms. J Neurosci Res 2010;88:3198-205. [DOI: 10.1002/jnr.22480] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
32 Tanaka Y, Sekiguchi F, Hong H, Kawabata A. PAR2 triggers IL-8 release via MEK/ERK and PI3-kinase/Akt pathways in GI epithelial cells. Biochem Biophys Res Commun. 2008;377:622-626. [PMID: 18854173 DOI: 10.1016/j.bbrc.2008.10.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
33 Gardell LR, Ma JN, Seitzberg JG, Knapp AE, Schiffer HH, Tabatabaei A, Davis CN, Owens M, Clemons B, Wong KK, Lund B, Nash NR, Gao Y, Lameh J, Schmelzer K, Olsson R, Burstein ES. Identification and characterization of novel small-molecule protease-activated receptor 2 agonists. J Pharmacol Exp Ther 2008;327:799-808. [PMID: 18768780 DOI: 10.1124/jpet.108.142570] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
34 Guerios SD, Wang ZY, Boldon K, Bushman W, Bjorling DE. Blockade of NGF and trk receptors inhibits increased peripheral mechanical sensitivity accompanying cystitis in rats. Am J Physiol Regul Integr Comp Physiol 2008;295:R111-22. [PMID: 18448607 DOI: 10.1152/ajpregu.00728.2007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 3.8] [Reference Citation Analysis]
35 Yang H, McNearney TA, Chu R, Lu Y, Ren Y, Yeomans DC, Wilson SP, Westlund KN. Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model. Mol Pain. 2008;4:8. [PMID: 18307791 DOI: 10.1186/1744-8069-4-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
36 Kawabata A, Matsunami M, Sekiguchi F. Gastrointestinal roles for proteinase-activated receptors in health and disease. Br J Pharmacol. 2008;153 Suppl 1:S230-S240. [PMID: 17994114 DOI: 10.1038/sj.bjp.0707491] [Cited by in Crossref: 56] [Cited by in F6Publishing: 67] [Article Influence: 3.5] [Reference Citation Analysis]
37 Barry GD, Suen JY, Low HB, Pfeiffer B, Flanagan B, Halili M, Le GT, Fairlie DP. A refined agonist pharmacophore for protease activated receptor 2. Bioorganic & Medicinal Chemistry Letters 2007;17:5552-7. [DOI: 10.1016/j.bmcl.2007.08.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
38 Fregni F, Pascual-Leone A, Freedman SD. Pain in chronic pancreatitis: a salutogenic mechanism or a maladaptive brain response? Pancreatology 2007;7:411-22. [PMID: 17898531 DOI: 10.1159/000108958] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
39 Ishikura H, Nishimura S, Matsunami M, Tsujiuchi T, Ishiki T, Sekiguchi F, Naruse M, Nakatani T, Kamanaka Y, Kawabata A. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents. Life Sciences 2007;80:1999-2004. [DOI: 10.1016/j.lfs.2007.02.044] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
40 Michalski CW, Laukert T, Sauliunaite D, Pacher P, Bergmann F, Agarwal N, Su Y, Giese T, Giese NA, Bátkai S, Friess H, Kuner R. Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis. Gastroenterology 2007;132:1968-78. [PMID: 17484889 DOI: 10.1053/j.gastro.2007.02.035] [Cited by in Crossref: 74] [Cited by in F6Publishing: 82] [Article Influence: 4.6] [Reference Citation Analysis]
41 Liu J, Li F. New developments in the relationship between protease activated recerptor-2 and alimentary system diseases. Shijie Huaren Xiaohua Zazhi 2007; 15(9): 986-990 [DOI: 10.11569/wcjd.v15.i9.986] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Lechin F, van der Dijs B. Central nervous system circuitry involved in the hyperinsulinism syndrome. Neuroendocrinology 2006;84:222-34. [PMID: 17167239 DOI: 10.1159/000098005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
43 Kawabata A. Folia Pharmacol Jpn 2006;128:82-87. [DOI: 10.1254/fpj.128.82] [Reference Citation Analysis]